A repeats-in-toxin (RTX) leukotoxin and its integrin receptor aggregate in cholesterol-rich lipid rafts. Results: The toxin's affinity to cholesterol is driven by a cholesterol recognition/amino acid consensus (CRAC) motif. Conclusion: Leukotoxin cytotoxicity is regulated by the CRAC motif. Significance: Other RTX toxins contain this CRAC motif, suggesting a role for cholesterol recognition in RTX cytolysis. The affinity was specific to cholesterol and required an intact secondary structure.
multi-step cascade and results in targeted cell death (2) . LtxA is a member of the repeats-in-toxin (RTX) family of cytotoxic proteins (3) which share cell-type specificity that is driven by their association with 2 integrin heterodimers, such as lymphocyte-function associated antigen-1 (LFA-1) (4) and macrophage-1 antigen (Mac-1)/complement receptor 3 (CR3) (5) .
Five genes are required for successful translation and secretion of LtxA (the structural toxin gene product) in A. actinomycetemcomitans. Four of the genes, ltxCABD (in transcriptional order) are located in the leukotoxin operon. A fifth gene, tdeA (6) , is not part of the ltx operon and is located 572 kb downstream of this site. Prior to secretion, Gram-negative bacterial protein toxins are translated as protoxins and must be post-translationally modified in order to achieve biological activity.
This modification takes various forms with bacterial protein toxins. In the case of RTX toxins, the RTXC protein, an acylase, catalyzes the attachment of fatty acyl chains to internal lysine residues of the toxin (7) (8) (9) in the bacterial cytoplasm; this acylation process is necessary for the toxin to achieve its biological activity (10) . The remaining three gene products (LtxB, LtxD and TdeA) form a type I secretion system and export LtxA directly from the bacterial cytoplasm to the external environment without the need for a periplasmic intermediates.
Hydropathy analysis of the amino acid sequence of LtxA (114.5 kDa; 1055 amino acids) (35, 36) in combination with algorithms predicting secondary structure (37, 38) permit the division of permit LtxA into four domains: hydrophobic, central, repeat, and C-terminal domains (35, 36) (Fig. 1A) . The hydrophobic domain (residues 1-420) contains a preponderance of hydrophobic amino acids and suggests an involvement in membrane insertion.
Secondary structure predictions of the region show half of the residues form either amphipathic or hydrophobic -helices, which are often associated with toxin-target cell membrane interactions. Comparison of the amino acid sequence of LtxA with other RTX toxins, such as E. coli HlyA and Mannheimia haemolytica LktA, show a remarkable concordance in the clustering of hydrophobic and hydrophilic residues among the three toxins in this area (35, 36) . The central domain (residues 421-730) is composed largely of hydrophilic residues, and the conservation of structure among the various RTX toxins is less strong. Located within the central region are the two acylated lysine residues (K 562 and K 687 ) that are necessary for biological activity (10) (Fig. 1A , red circles labeled "A"). The repeat region (residues 730-900) contains a series of fourteen repeated nonapeptides with the consensus sequence of GGXG(N/D)DX(L/I/F)X (where X represents any amino acid), which together form a unique calcium binding structure that is called a parallel β-helix or parallel β-roll (39, 40) . LtxA has been shown to bind calcium as well (41) . Finally the C-terminal domain (901 -1055) is required for secretion (42) .
The RTX toxins are known to be secreted into the aqueous solution but also to be membraneinteracting proteins (11) . Neither the watersoluble nor membrane-embedded structures of these toxins (and LtxA in particular) have been solved; however, it has been proposed that this family of toxins undergoes a conformational change upon membrane association (12) . We have recently shown that LtxA undergoes distinct lipidspecific secondary structure changes upon binding to or disruption lipid bilayers (13) .
LtxA and other RTX toxins bind to various 2 integrins and cluster in lipid rafts (14) (15) (16) . The result of this interaction mimics aspects of the integrin (17) activation signal, including the elevation of cytosolic Ca 2+ , activation of calpain, and cleavage of talin. The cleavage of talin frees LFA-1 from the cytoskeleton and allows lateral movement of the LFA-1/LtxA complex to lipid rafts (14) . While talin cleavage and release of LFA-1 is the initial step in toxin/integrin-driven raft clustering, the process that moves the LtxA/LFA-1 complex to and subsequently maintains them in the raft is not clear. This observation has led us to hypothesize that LtxA has an affinity for cholesterol, a primary raft component, and this interaction may be responsible for the LtxA/LFA-1 clustering observed in intoxicated cells.
EXPERIMENTAL PROCEDURES
Chemicals -Sodium chloride (NaCl), calcium chloride (CaCl2), sodium azide (NaN3), 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES), cholesterol, guanidine hydrochloride (GuHCl) and potassium phosphate monobasic (KH2PO4) were purchased from Sigma Chemical Co. (St. Louis, MO). Lipids, including 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (SOPC) and 1,2-dioleoyl-snglycero-3-phosphocholine (DOPC), were purchased from Avanti Polar Lipids (Alabaster, AL).
Ergosterol was purchased from MP Biomedicals (Solon, OH).
Peptides were synthesized and purified (98% purity) by Biomatik (Wilmington, DE).
Bacterial strains, growth conditions, and plasmids -Three A. actinomycetemcomitans strains were used in this work, JP2, CS001, and SM003 (18) . JP2 produces a wild-type LtxA (LtxA wt ), CS001 lacks the ltxC gene and therefore produces an unacylated LtxA (LtxA CS001 ), and SM003 has been complemented with the ltxC gene in trans and produces an acylated LtxA (LtxA
SM003
). The A. actinomycetemcomitans strains were grown overnight in AAGM broth (19) supplemented with antibiotics (JP2: 12.5 g/mL vancomycin and 75 ug/mL bacitracin, CS001: 40 g/mL kanamycin, SM003: 40 ug/mL kanamycin and 2 g/mL chloramphenicol).
LtxA was purified as described previously (20) . The purity of the toxin was confirmed by Coomasie staining of SDS-PAGE and the specificity by crossreactiviety with anti-LtxA antibody (Western blot).
We confirmed the activity using a cytotoxicity assay. The purity of the three proteins is shown in Fig. 1B , and the cytotoxicity is shown in Table 1 .
Production of CRAC-mutant LtxA was accomplished in E. coli using a pSHH plasmid, a pUC19-based plasmid containing the ltxA promoter, ltxC, and ltxA (21) . Active LtxA is constitutively expressed in the cytosol.
The CRAC mutants were constructed by substituting proline for tyrosine at amino acid positions 336 (for CRAC Y336P ) or 503 (for CRAC Y503P ) of ltxA. Site-directed mutagenesis was performed using a QuikChange® Site-Directed Mutagenesis Kit (Agilent Technologies, Inc. Santa Clara, CA), according to the manufacturer's instructions. The primers containing substitutions were designed using the OligoPerfect TM Designer (http://bioinfo.invitrogen.com/oligoDesigner/) as shown in Table 2 . The reactions were performed on an automated thermal cycler with an initial step of 30 sec at 95 °C, followed by PCR amplification for 16 cycles of 30 sec at 95 °C, 1 min at 55 °C, and 3 min at 68 °C. The obtained PCR products were transformed into DH5α-T1 cells, and the mutant clones were selected on LB agar plates with 50 μg/ml of ampicillin. CRAC Y336P and CRAC Y503P were produced from E. coli using the following procedure. Overnight cultures of E. coli DH5α-T1 containing the plasmid were used at a 1 to 50 dilution to inoculate 200 ml LB/ampicillin (50 µg/ml), which was grown to an OD600 of approximately 0.4.
The cultures were centrifuged and resuspended in 6 ml of buffer (20 mM Tris-HCl, 250 mM NaCl, 0.2 mM CaCl2, pH 6.8), sonicated (45 seconds x 6, on ice), and centrifuged to remove cell debris (12,000g, 15 min, 4 °C).
LtxA (LtxA enatured ) was denatured by incubating 1 uM LtxA wt with an equal volume of 16 M GuHCl overnight (12) . Following incubation, the GuHCl was exchanged with liposome buffer (150 mM NaCl, 5 mM CaCl2, 5 mM HEPES, and 3 mM NaN3, pH 7.4) for use in the SPR experiments.
Cell Culture -Jn.9, a subclone of the Jurkat cell line (22) , a gift from Dr. Lloyd Klickstein (Novartis Institute for Biomedical Research, Cambridge, MA), was maintained as described previously (23) . 2 mM L-glutamine, and 50 ug/mL gentamicin.
Liposome preparation -Lipids dissolved in chloroform were added to a glass vial in the required amounts (24) . The chloroform was evaporated under a stream of nitrogen, and the residual chloroform was removed under vacuum, creating a thin lipid film on the glass surface. Liposomes were created by hydrating the lipid film with liposome buffer (150 mM NaCl, 5 mM CaCl2, 5 mM HEPES, 3 mM NaN3, pH = 7.4). Unilamellar liposomes (LUVs) were formed by extruding the liposome solutions through a 200-nm polycarbonate membrane (24, 25) .
The lipid compositions used in this work were chosen based on their raft-like nature (26) . The liposomes were composed of DMPC with 0%, 20%, 40%, or 60% cholesterol (or ergosterol). At room temperature, DMPC with 0% cholesterol exists in a nonraft-like state (liquid disordered), at 40% and 60% cholesterol, DMPC exists in a raftlike state (liquid ordered), and at 20% cholesterol, both phases coexist (27, 28) .
Circular Dichroism Spectroscopy -The extent of unfolding of LtxA enatured was determined using circular dichroism (CD) spectroscopy. Three LtxA samples were prepared at a concentration of 7 M. 1) Native LtxA wt was suspended in liposome buffer, 2) LtxA denatured was prepared as described above (12) and left in GuHCl, and 3) LtxA enatured was prepared as described above and the buffer was exchanged with liposome buffer (to recreate the conditions of the SPR experiment).
CD spectroscopy analysis was performed on a Jasco J-810 spectropolarimeter, as discussed in our previous studies (29) . The samples were analyzed at 25°C in a 0.2-mm path length quartz cell using the step-scanning mode from 260 to 200 nm, with a 1-nm wavelength step, 10-s averaging time, and 1-nm band width. The spectra were recorded under identical conditions for an n =3 for each sample.
Surface Plasmon Resonance -Liposomes were tethered to an L1 Biacore chip by flowing them over the chip at a rate of 5 uL/min, until a mass corresponding to approximately 1000 response units (RU) (approximately 5 µL) had been added to the surface (30) . A small volume of NaOH (5 L) was added to remove unbound liposomes.
For kinetic analysis, the flow rate was increased to 30 L/min before the toxin injection was initiated. Each toxin injection was 60 L, followed by a 180-L dissociation of buffer only. The surface was regenerated with an injection of 65 L 0.5% SDS. The ten toxin concentrations ranged from 0 nM to 500 nM in a 1:2 dilution series. All SPR measurements were performed on a Biacore ® 3000, and the data were evaluated using the BIAevaluation ® software. The data were fit using a 1:1 Langmuir binding model to obtain the equilibrium dissociation constant (KD), as well as the association (ka) and dissociation (kd) rates, where KD is given by:
For steady state competition analysis, liposomes containing 40% cholesterol were tethered to an L1 chip. The flow rate was set at 5 L/min, and 50 L of toxin was injected, followed by a 25-L dissociation of buffer only. The surface was regenerated with SDS, as described above. In the CRAC peptide competition experiments, the toxin, at a concentration of 1000 nM, was incubated with an equal volume of peptide at concentrations of 0 nM, 500 nM, 1000 nM, 2000 nM, and 4000 nM (molar LtxA:peptide ratios of 1:0, 1:0.5, 1:1, 1:2, and 1:4). The inhibition was defined as:
where RLtxA is the response units of the LtxA-only run, and RULtxA/peptide is the response units of each run containing LtxA and peptide. Response units represent the surface coverage. The response units were measured at the end of the injection, just before the dissociation was initiated, at the same time point for each experiment.
In the comparison of binding to cholesterolcontaining liposomes by the acylation mutant toxins, LtxA CS001 and LtxA SM003 at a concentration of 250 nM were injected over liposomes containing 40% cholesterol that had been tethered to the L1 chip.
Differential Scanning Calorimetry -The DSC experiments were performed as described previously (31) , with the following modifications. Approximately 1 mg of the dried peptide was resuspended in 100 μL methanol and added to a solution of SOPC with or without cholesterol in a chloroform:methanol (2:1) to give the desired final ratio of peptide to lipids. The solvent was removed under nitrogen gas, and the final traces of solvent were removed in a vacuum desiccator. The films were hydrated with PIPES buffer (20 mM PIPES, 140 mM NaCl, 1 mM EDTA, adjusted to pH 7.4) and vortexed extensively. The suspension was degassed and loaded into the sample cell of a Nano II differential scanning calorimeter (Calorimeter Sciences Corp., Lindon, UT). Buffer was placed in the reference cell. Successive heating and cooling scans were run between 0 and 45 o C, at a scan rate of 1 o /min. Cytotoxicity -A trypan blue cytotoxicity assay was used to measure cell viability (32) . The percentage of cells killed by each treatment was calculated by:
where #t=0 is the number of cells before treatment, and #t=5 is the number of cells after treatment. Each %kill value was normalized to the %kill value of LtxA alone.
The effect of the CRAC peptides on LtxAmediated cell death was measure in cytotoxicity assays, as described previously (23 In the case of the full-length LtxA CRAC mutants, 50 μg of total protein in the E. coli cytosolic fraction was added to 0.5 x 10 6 Jn.9 cells and incubated for 24 hours. Cell death was measured with a Trypan blue assay using a Vi-cell machine (Beckman Coulter, Hialeah, FL). Western blot analysis was used to confirm LtxA expression. An E. coli DH5α-T1 cytosolic fraction that did not contain pSHH served as a control.
Statistical Analysis -The statistical analyses were performed using either Student's t-test or one-way analysis of variance (ANOVA) using SigmaPlot ® (Systat ® Software, Inc. Chicago, IL). The following statistical criteria were applied: p < 0.001, p < 0.05, p < 0.01.
RESULTS
LtxA has a strong affinity for cholesterol - These SPR sensorgrams were used to calculate the kinetic parameters of binding. The affinity of LtxA for the membranes increased (KD decreased) as the amount of cholesterol increased up to 40% and then decreased (KD increased) in membranes containing 60% cholesterol (Fig. 2E) .
The maximal affinity (minimal KD) to membranes containing 40% cholesterol was approximately four orders of magnitude greater (10 -12 M) than the affinity for cholesterol-free membranes (10 -8 M). Table 3 shows the corresponding association (ka) and dissociation (kd) rates for the binding of LtxA to liposomes containing 0 to 60% cholesterol. There was no significant change in the association rate as the amount of cholesterol increased; however, the dissociation rate decreased as the amount of cholesterol in the membranes increased to 40% and then increased at 60% cholesterol. Therefore, the affinity of LtxA to cholesterol, as measured by the KD, is almost entirely due to cholesterol-dependent changes in the dissociation rate rather than changes in the association rate.
Binding is specific for cholesterol -We then compared the affinity of LtxA for liposomes composed of DMPC and varying amounts of the sterol, ergosterol (substituted for cholesterol), as a specificity control. The structures of these two sterols are similar, with ergosterol containing an additional double bond in the B ring and a double bond on carbon 22. The SPR sensorgrams showing LtxA association to and dissociation from membranes containing 0%, 20%, 40%, and 60% ergosterol are shown in Fig. 2 F , G, H, and I, respectively.
As shown in Fig. 3J , the KD remained essentially constant as the ergosterol composition increased, with no strong affinity observed at high sterol compositions. The difference between Fig.  2E and J indicates that the strong affinity of LtxA to sterol-containing membranes is specific for cholesterol.
Membranes composed of DMPC and cholesterol are known to phase separate into cholesterol-poor (liquid-disordered, ld) and cholesterol-rich (liquid-ordered, lo) regions, depending on the temperature and cholesterol composition of the system (28) . The lo phase is often used as a model of lipid rafts because of their similar compositions (rich in cholesterol and saturated lipids, poor in unsaturated lipids).
To determine whether the affinity of LtxA for cholesterol-containing membranes is determined by the cholesterol composition or by the raft-like nature of the membrane, we compared the affinity of LtxA for membranes composed of 60% DOPC (unsaturated)/40% cholesterol, a lipid composition that is ld (nonraft-like), with membranes composed of 60% DMPC (saturated)/40% cholesterol, a lipid composition that is lo (raft-like).
The SPR sensorgrams showing LtxA association to and dissociation from membranes containing DOPC and 0%, and 40%, cholesterol are shown in Fig. 2 K and L, respectively. The affinity of LtxA for membranes containing 40% cholesterol was not significantly different for the two lipid types (Fig.  3M) , demonstrating that it is the presence of cholesterol that regulates this strong affinity, rather than the raft-like nature of the membrane.
To determine if a specific LtxA structural element regulates the affinity of the toxin for cholesterol, we studied the binding of enatured LtxA (LtxA enatured ) to DMPC membranes containing varying amounts of cholesterol. The binding of LtxA enatured to membranes containing 0%, 20%, 40%, or 60% cholesterol as a function of time is shown in Figs. 3A , B, C, and D, respectively. As shown in Fig. 3E , similarly to folded LtxA, the affinity of LtxA enatured reached a maximum at 40% cholesterol (minimum in KD); however, this maximum is less pronounced (by three orders of magnitude) than the maximum affinity of native LtxA for cholesterol-containing membranes (Fig. 2E ) and is not statistically significant. Table 3 shows the corresponding association (ka) and dissociation (kd) rates. This result is consistent with a model in which the affinity of LtxA for cholesterol-containing membranes requires the intact secondary structure of the protein.
The extent of LtxA unfolding with GuHCl in the LtxA enatured sample was analyzed by CD. As shown in the inset of Fig. 3E , the CD spectra of LtxA wt (solid lines) indicated that the protein was folded and contained some secondary structure. In contrast, the CD spectra of LtxA denatured in 8M GuHCl (dashed lines) shows that the GuHCl has unfolded the protein. After GuHCl exchange with liposome buffer, LtxA enatured (dotted lines) adopted a similar, but distinct shape as LtxA wt , indicating that the toxin remains partially unfolded. The final GuHCl concentration in the liposome-bufferexchanged sample was 2 M; previous work has shown that at this GuHCl concentration, LtxA loses its ability to kill target cells (12) .
LtxA affinity for cholesterol is independent of its acylation status -LtxA is posttranslationally modified by the addition of two fatty chains to two internal lysines (33) . For some proteins, acylation has been proposed to enhance membrane association (34) .
We therefore investigated whether the association of LtxA with cholesterol depends on the presence of the acyl groups by using a nonacylated mutant (LtxA CS001 ) and a reconstructed mutant (LtxA SM003 ). The purity and cytotoxicity of these mutants is shown in Fig. 1B and Table 1 . We measured the binding of these mutant toxins to cholesterol using a steady-state SPR assay. The SPR sensorgrams are shown in Fig. 4A , and the maximal response units (a measure of binding) are shown in Fig. 4B . Binding to cholesterol was enhanced in the absence of acyl chains, relative to the fully acylated protein, LtxA SM003 , indicating that acylation is not responsible for the strong affinity of LtxA for cholesterol, and it may actually inhibit binding to cholesterol.
LtxA contains cholesterol recognition/amino acid consensus (CRAC) sites -The high affinity binding of LtxA to cholesterol suggests the presence of a lipid binding site(s) within the LtxA protein.
We scanned the LtxA amino acid sequence of the toxin for CRAC sites using for L/V-X1-5-Y-X1-5-R/K CRAC site motif (43) which has been shown to to be associated with cholesterol binding. We identified two putative CRAC sites within the Table 5 ). The first set of peptides (CRAC 336 ) corresponds to the CRAC site between residues 333 and 339, and the second set (CRAC 503 ) corresponds to the CRAC site between residues 501 and 505. Within each set, peptide "WT" is the "wild type" sequence, peptide "MUT" contains a proline in place of the central tyrosine residue (the central tyrosine has been shown to be critical for cholesterol binding (44)), and peptide "SCM" contains the scrambled CRAC sequence.
The interaction of each of these peptides with cholesterol-containing membranes was measured using DSC. The peptide-induced rearrangement of cholesterol in a membrane into cholesterol-rich domains can be followed by measuring the formation of cholesterol crystallites when the sterol passes its solubility limit. The formation of these crystallites can be readily detected with DSC through their polymorphic thermal transition, which occurs with a characteristic hysteresis, appearing at approximately 35 o C in heating scans and at approximately 23 o C in cooling scans at most conventional scan rates (45) .
As shown in Table 6 , none of the CRAC peptides caused a change in the phase transition temperature of pure SOPC in the absence of cholesterol at a peptide mol fraction of 0.15. In addition, none of the CRAC 336 peptides caused any substantial change in the gel to liquid crystalline phase transition enthalpy, nor did CRAC peptide o C on cooling. In the presence of 15 mol% peptide, the characteristic transitions were observed for all peptides, as shown in Table  7 and Fig. 6 . The greatest enthalpies of these cholesterol crystallite transitions were observed with the two CRAC peptides, CRAC 336WT and CRAC 503WT ( (Figure 8, insert) . Following sonication, supernatants from each experimental group and controls were normalized for protein content and incubated with Jn.9 target cells. The cytotoxicity was measured with a Trypan blue cytotoxicity assay (32) .
Jn.9 cells exposed to LtxA WT sonicates expressed in E. coli had a reduced viability after 24 hrs of exposure (41.0% + 15.0%), when compared to a control sonicate that did not contain ltxA (94.4% + 0.5%, p < 0.001). Cells exposed to the CRAC Y503P mutant had a viability (49.7% + 19.3%, p = 0.02) that was only slightly higher than cells exposed to wild type toxin. However, the CRAC Y336P mutant was incapable of killing Jn.9 target cells (87.7% + 3.3%, p = 0.04). These results indicate that an intact CRAC 336 site is required for LtxA toxicity, while the CRAC 503 site plays only a limited role in toxicity.
DISCUSSION
LtxA-induced raft clustering is dependent upon a toxin-induced increase in cytosolic Ca 2+ , activation of calpain, and cleavage of talin, which allows mobilization to and subsequent clustering of LtxA and its receptor, LFA-1, in the lipid rafts (23) . Furthermore, other RTX toxins, such as a leukotoxin (Lkt) produced by M. haemolytica and the adenylate cyclase toxin (CyaA) produced by B.
pertussis, have been shown to have similar effects on raft and receptor clustering (46, 47) . Here, we describe a unique mechanism of cholesterol binding by LtxA, which we hypothesize to be involved in this previously reported RTX/receptor clustering in lipid rafts.
Cholesterol-rich lipid rafts are dynamic and complex structures that admit or exclude certain proteins; as such, they provide platforms for signaling cascades (48). For example, LFA-1 clustering in lipid rafts plays several important roles in the ontogeny of immune responses, such as the formation of an immunological synapse (49, 50) or the arrest of immune cells on endothelia expressing intercellular adhesion molecules (ICAMs) (51) . In addition, cholesterol-rich lipid rafts play central roles in the pathogenesis of various microorganisms in many different ways, including docking, internalization, hiding, hijacking cell signaling, and oligomerization (52) (53) (54) (55) (56) (57) (58) (59) .
FimH-expressing E. coli binds to the glycosylphosphatidylinositol-linked protein CD48, which is located in lipid rafts, as a first step in internalization (56) .
Bacteria, including Campylobacter jenjuni and Mycobacterium bovis, as well as viruses are internalized in raftdependent processes (53) (54) (55) 58) . A number of bacterial toxins, including streptolysin O, Vibrio cholerae cytolysin and anthrax toxin have been shown to use lipid rafts as a concentrating platform for oligomerization (52, 59 ) while thiolactivated/thiol-dependent streptolysins and listerolysin use raft lipids as receptors (57) .
The mechanism of lipid raft association and cholesterol binding by LtxA appears to be distinct from these previously reported mechanisms. We have shown that LtxA binds specifically to cholesterol-containing membranes in a unique mechanism with a strong cholesterol-dependent dissociation rate but a cholesterol-independent association rate (Fig. 2) 503WT and all of the control peptides had no effect on binding of LtxA to cholesterol. In addition, only CRAC 336WT , the only peptide to inhibit binding to cholesterol, inhibited LtxA-mediated cytotoxicity. This behavior is consistent with our previous work, in which we found that extraction of cholesterol from Jn.9 cells inhibits LtxA-mediated cytotoxicity (23) . In the panel of CRAC mutants, modification of CRAC 336 reduced the cytotoxicity of LtxA, while modification of CRAC 503 had only a limited effect on the cytotoxicity of LtxA.
Together, the results indicate that while both CRAC sites may interact with cholesterol, the first CRAC site, CRAC 336 , is responsible for cholesterol binding by LtxA. Interestingly, this first CRAC site is highly conserved among RTX toxins, indicating that this mechanism may be common to other members of this toxin family (Table 4 ). The second CRAC site, CRAC 503 , which appears to have a less important role in cholesterol binding and cytotoxicity of LtxA, is less conserved among the RTX toxins, appearing only in LtxA.
Our data indicate that cholesterol binding by LtxA is mediated by CRAC 336 ; however, we could not rule out the possibility that the acyl groups attached to LtxA could also be involved in the process. For some proteins, acylation is required for membrane binding (62-66) ; however, the role of acylation in the RTX toxins has not yet been conclusively determined (34) . Studies have shown that acylation does not affect the ability of E. coli -HlyA to bind to either erythrocytes or liposomes (67, 68) , but others have shown that acylation is involved in this process (69) (70) (71) . Alternatively, acylation of the RTX toxins has been proposed to be involved in protein-protein interactions or pore formation (34, 68, 69, 72) . Previously, we showed that the acyl chains on LtxA are saturated and/or hydroxylated (33) ; this hydroxylation may sterically inhibit association with cholesterolcontaining membranes, which are more tightly packed than cholesterol-poor membranes.
Acylation clearly plays a role in cytotoxicity, as the nonacylated mutant was unable to kill Jn.9 cells (Table 1) ; however, it appears that the role of acylation in the cytotoxic mechanism is not the binding to cholesterol, as there was no significant difference in the binding of acylated LtxA (LtxA ltxC/+ltxC ) to cholesterol compared to unacylated LtxA (LtxA ltxC ). LtxA is not the only toxin produced by A. actinomycetemcomitans that binds to cholesterol using CRAC sequences. The cytolethal distending toxin (Cdt) produced by this organism binds membrane cholesterol before gaining access to the cytoplasm, where it triggers cell cycle arrest (73) . Surprisingly, although both the A. actinomycetemcomitans-produced Cdt and LtxA bind cholesterol via CRAC sites, the mechanisms of binding of the toxins are quite different. The affinity of the Cdt for cholesterol occurs through an increased association rate when binding to cholesterol and cholesterol-rich rafts (73) , suggesting that the Cdt uses cholesterol as a receptor. Conversely, the affinity of LtxA for cholesterol is not dependent upon differences in association rate (ka); rather, it is influenced by the cholesterol-dependent change in dissociation rate (kd), suggesting that LtxA is more indiscriminate in its binding, but once bound to cholesterol, the attachment is almost irreversible.
The lipid compositions used in this work were specifically chosen for their raft-forming nature. At room temperature, a membrane composed of DMPC and 0% cholesterol exists in a nonraft-like (liquid-disordered) phase, while at 40% and 60% cholesterol, the membrane exists in a raft-like (liquid-ordered phase) (27, 28) . In vitro, the lipid composition of lipid rafts is often approximately 30% (74) (75) (76) (77) . The cholesterol compositions used in this work are valid in both an in vitro and in vivo context.
Previous work in our lab found that LtxA is located in lipid rafts only after it has bound to its receptor, LFA-1. Before the binding of LtxA, LFA-1 is located outside of the raft, and upon LtxA binding, the LtxA/LFA-1 complex moves to the raft, causing large-scale clustering (23) . Here, we demonstrated that the association rate of LtxA to membranes does not change with the cholesterol composition; in other words, LtxA does not have a clear preference for binding to cholesterol, an observation that is consistent with this previous paper, in which LtxA was found in both raft (cholesterol-rich) and nonraft (cholesterol-poor) regions of the membrane. Once LtxA binds to cholesterol, however, it remains tightly bound, providing a possible mechanism for the observed LtxA/LFA-1 clustering in lipid rafts (Fig. 9) . Movement of proteins in and out of rafts is often transient (78) (79) (80) , and LFA-1 has been shown to reside in two subsets: one within rafts and one outside (81) . We hypothesize that LFA-1 is able to move into and out of rafts until it is bound by LtxA, at which point, LtxA binds tightly to cholesterol, holding the LtxA/LFA-1 complex in the raft and allowing the formation of large clusters within the raft. Because we have found that binding of LtxA to cholesterol is essential for LtxA-mediated cell death, we propose that this cholesterol-dependent clustering is a key step in the cytotoxicity of LtxA.
The specific binding of other RTX toxins to cholesterol has not been reported previously, although it has been shown that both CyaA and Lkt cause a receptor/toxin clustering in lipid rafts (46, 47) . The mechanism of raft clustering by Lkt is similar to what we have reported for LtxA; here, we have shown that Lkt shares CRAC 336 with LtxA, suggesting that the binding of cholesterol by this RTX toxin may drive this receptor-dependent clustering in lipid rafts. However, CyaA, which does not contain either of the two CRAC sites, has been shown to induce the clustering of M2 integrins in lipid rafts (47) . The mechanism by which CyaA clusters in rafts differs slightly from the mechanism used by LtxA (47); an interesting question will be if this difference in mechanism can be explained by the lack of a CRAC site in CyaA or the fact that CyaA binds to a different 2 integrin than does LtxA.
In this work, we have identified a unique, but likely conserved mechanism of cholesterol binding by a bacterial toxin. The binding of cholesterol by LtxA occurs in an indirect fashion but appears to regulate the cholesterol dependence of LtxA cytotoxicity. a LtxA wt or LtxA enatured was injected over liposomes composed of varying amounts of cholesterol tethered to a L1 chip. The rates of association and dissociation (ka and kd, respectively) were fit to a 1:1 Langmuir binding model, using the BIAevaluation software. The values represent the mean of four independent experiments + the standard deviation. by guest on November 19, 2017 
